15-71811455-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014249.4(NR2E3):c.119-28T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0488 in 1,502,626 control chromosomes in the GnomAD database, including 4,405 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 1303 hom., cov: 32)
Exomes 𝑓: 0.043 ( 3102 hom. )
Consequence
NR2E3
NM_014249.4 intron
NM_014249.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0690
Publications
2 publications found
Genes affected
NR2E3 (HGNC:7974): (nuclear receptor subfamily 2 group E member 3) This protein is part of a large family of nuclear receptor transcription factors involved in signaling pathways. Nuclear receptors have been shown to regulate pathways involved in embryonic development, as well as in maintenance of proper cell function in adults. Members of this family are characterized by discrete domains that function in DNA and ligand binding. This gene encodes a retinal nuclear receptor that is a ligand-dependent transcription factor. Defects in this gene are a cause of enhanced S cone syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
NR2E3 Gene-Disease associations (from GenCC):
- retinitis pigmentosa 37Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Goldmann-Favre syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 15-71811455-T-C is Benign according to our data. Variant chr15-71811455-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NR2E3 | ENST00000617575.5 | c.119-28T>C | intron_variant | Intron 1 of 7 | 1 | NM_014249.4 | ENSP00000482504.1 | |||
| NR2E3 | ENST00000621098.1 | c.119-28T>C | intron_variant | Intron 1 of 6 | 1 | ENSP00000479962.1 | ||||
| NR2E3 | ENST00000621736.4 | c.-146-28T>C | intron_variant | Intron 3 of 9 | 2 | ENSP00000479254.1 |
Frequencies
GnomAD3 genomes AF: 0.104 AC: 14838AN: 143252Hom.: 1297 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
14838
AN:
143252
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0722 AC: 11125AN: 154168 AF XY: 0.0671 show subpopulations
GnomAD2 exomes
AF:
AC:
11125
AN:
154168
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0430 AC: 58487AN: 1359280Hom.: 3102 Cov.: 32 AF XY: 0.0430 AC XY: 28870AN XY: 670768 show subpopulations
GnomAD4 exome
AF:
AC:
58487
AN:
1359280
Hom.:
Cov.:
32
AF XY:
AC XY:
28870
AN XY:
670768
show subpopulations
African (AFR)
AF:
AC:
6776
AN:
26026
American (AMR)
AF:
AC:
4589
AN:
34662
Ashkenazi Jewish (ASJ)
AF:
AC:
489
AN:
24732
East Asian (EAS)
AF:
AC:
8550
AN:
35392
South Asian (SAS)
AF:
AC:
4551
AN:
78576
European-Finnish (FIN)
AF:
AC:
1817
AN:
45616
Middle Eastern (MID)
AF:
AC:
248
AN:
4250
European-Non Finnish (NFE)
AF:
AC:
28194
AN:
1054280
Other (OTH)
AF:
AC:
3273
AN:
55746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2518
5036
7555
10073
12591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1236
2472
3708
4944
6180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.104 AC: 14890AN: 143346Hom.: 1303 Cov.: 32 AF XY: 0.104 AC XY: 7256AN XY: 69942 show subpopulations
GnomAD4 genome
AF:
AC:
14890
AN:
143346
Hom.:
Cov.:
32
AF XY:
AC XY:
7256
AN XY:
69942
show subpopulations
African (AFR)
AF:
AC:
9043
AN:
35540
American (AMR)
AF:
AC:
1601
AN:
14650
Ashkenazi Jewish (ASJ)
AF:
AC:
63
AN:
3430
East Asian (EAS)
AF:
AC:
1049
AN:
5126
South Asian (SAS)
AF:
AC:
332
AN:
4808
European-Finnish (FIN)
AF:
AC:
441
AN:
9824
Middle Eastern (MID)
AF:
AC:
16
AN:
290
European-Non Finnish (NFE)
AF:
AC:
2114
AN:
66790
Other (OTH)
AF:
AC:
191
AN:
1986
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
692
1384
2075
2767
3459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.